Abstract
Contemporary data confirm that there has been racial diversification in clinical trials over the past 20 years, yet minority participation in trials still lags behind their share of the U.S. population. Experts agree that provider education and care navigators are key to enrolling traditionally underrepresented groups in trials, but widespread implementation of these strategies is needed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
